Table 2.
Best fit values† | Literature values | ||||||||
Enzyme | Pathway | Parameter‡ | Ratio | H,§ ‰ | ,¶ ‰ | ,∥‰ | In vitro KIE | Ref. | |
G6PDH | PP and ED | 7.05 10−5 | — | 2.97 | (45) | ||||
6PGDH | PP | 1.08 10−4 | — | 1.61 | (46) | ||||
ICDH | TCA cycle | 2.99 10−4 | — | +1,085 | 0 | 1 | (26, 42, 47) | ||
ME | Anaplerotic node | 0.00 | — | — | — | 1.47 | (45) | ||
PntAB | — | 3.46 10−5 | — | to | 1.8–4.5 | (27) | |||
unknown | — | 0.00 | — | — | — | — | — | — | |
UdhA | — | — | 0.84 | — | — | — | — | ||
sTH or other | — | — | 0.57 | — | — | — | — |
Best-fit parameters were derived by minimizing the rms difference between experimental data and predicted lipid H values from Eqs. 1–3. Uncertainties associated with these values are discussed in SI Appendix, Fig. S4.
and account for the membrane-bound (PntAB) and soluble (UdhA) transhydrogenase from E. coli, respectively. account for the soluble transhydrogenases (sTH) or alternative mechanisms to balance NADPH levels in all other species. accounts for a currently unknown mechanism to balance NADPH levels in B. subtilis.
H values were calculated as H = (/ − 1) 1,000.
Enrichment factors were estimated as = ( − 1) 1,000 and = (H + 1)/( + 1) − 1.
Enrichment factors are calculated from in vitro KIEs according to = (1/KIE − 1) 1,000.